TYK2 inhibitor (Neuron23)

N/A

Report date: 2025/01/26 17:34:55
NME

Base Information

Drug NameTYK2 inhibitor (Neuron23)
Drug Alias Nametyrosine kinase 2 inhibitors (Neuron23)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionTyrosine-protein kinase JAK2 inhibitors
TargetsTyrosine-protein kinase JAK2
Therapy Area/IndicationsInflammationNeuritisMultiple Sclerosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryGermany
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesOrigenis GmbH
China Registration ClassN/A

Develop Information

Active CompaniesNeuron23 Inc
Inactive CompaniesOrigenis GmbH
Active IndicationsInflammationNeuritisMultiple Sclerosis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A